Sample Page
Author:
Royal Philips
Posted Date:
May 8, 2026
Philips shareholders approve all proposals at the AGM 2026
Royal Philips
May 8, 2026
Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated
Royal Philips
May 6, 2026
Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction
Royal Philips
April 23, 2026
Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning
Royal Philips
April 22, 2026
Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications
Royal Philips
April 16, 2026
MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member
Royal Philips
April 2, 2026
FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair
Royal Philips
March 26, 2026
Philips launches IntraSight Plus to simplify coronary interventions and advance precision care
Royal Philips
March 25, 2026
Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant
Royal Philips
March 24, 2026
Philips convenes the Annual General Meeting of Shareholders 2026
Royal Philips
March 23, 2026
1
2
Next
